Fidelity International’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.36M Buy
8,278
+1,074
+15% +$602K ﹤0.01% 709
2026
Q1
$4.05M Sell
7,204
-9,551
-57% -$6.12M ﹤0.01% 713
2025
Q4
$11.3M Buy
16,755
+1,495
+10% +$1.02M 0.01% 567
2025
Q3
$9.75M Buy
15,260
+14,772
+3,027% +$8.97M 0.01% 569
2025
Q2
$262K Buy
+488
New +$233K ﹤0.01% 840
2024
Q4
Sell
-2,465
Closed -$1.25M 951
2024
Q3
$1.25M Sell
2,465
-247
-9% -$120K ﹤0.01% 719
2024
Q2
$1.32M Buy
2,712
+2,676
+7,433% +$1.34M ﹤0.01% 713
2024
Q1
$19.4K Hold
36
﹤0.01% 829
2023
Q4
$20K Hold
36
﹤0.01% 792
2023
Q3
$15.7K Buy
+36
New +$18K ﹤0.01% 759
2021
Q2
Sell
-4
Closed -$2K 959
2021
Q1
$2K Sell
4
-386
-99% -$193K ﹤0.01% 858
2020
Q4
$195K Buy
390
+386
+9,650% +$173K ﹤0.01% 724
2020
Q3
$2K Hold
4
﹤0.01% 834
2020
Q2
$1K Sell
4
-58
-94% -$16.8K ﹤0.01% 841
2020
Q1
$15K Buy
62
+60
+3,000% +$15.7K ﹤0.01% 691
2019
Q4
$1K Sell
2
-2
-50% -$527 ﹤0.01% 884
2019
Q3
$1K Hold
4
﹤0.01% 822
2019
Q2
$1K Buy
4
+1
+33% +$246 ﹤0.01% 832
2019
Q1
$1K Sell
3
-29
-91% -$5.99K ﹤0.01% 812
2018
Q4
$6K Sell
32
-79,483
-100% -$16.3M ﹤0.01% 726
2018
Q3
$19.9M Buy
79,515
+5,806
+8% +$1.41M 0.03% 393
2018
Q2
$16.1M Buy
+73,709
New +$15.2M 0.02% 426

Other funds holding IDXX

Fidelity International's IDXX Position: Q2 2026 in Review

Fidelity International increased its Idexx Laboratories (IDXX) stake by 15% in Q2 2026, buying an estimated $602K and bringing the position to 8,278 shares worth $4.36M. The position accounts for ﹤0.01% of the portfolio, ranked #709.

Fidelity International first reported a position in IDXX in Q2 2018 and has held it in 22 quarters since. The position peaked at $19.9M in Q3 2018. 1,137 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Fidelity International held 8,278 shares of Idexx Laboratories worth $4.36M as of Q2 2026.
  • Fidelity International bought 1,074 Idexx Laboratories shares in Q2 2026, an estimated $602K.
  • Idexx Laboratories made up ﹤0.01% of Fidelity International's portfolio in Q2 2026, its #709 holding.
  • Fidelity International first reported a position in Idexx Laboratories in Q2 2018 and has held it in 22 quarters since.
  • Fidelity International's Idexx Laboratories position peaked at $19.9M in Q3 2018.
  • 1,137 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Fidelity International's 13F filing for Q2 2026, filed 13 Aug 2026.